2014China Foreign Medical TreatmentRequires access

Observation on the Efficacy of Alprostadil in the Treatment of Diabetic Peripheral Neuropathy

Chen Guochon

Open publisher page 0 citations

Abstract

Objective To study and analyze the effect of alprostadil on diabetic peripheral neuropathy. Methods 102 patients with diabetic peripheral neuropathy were randomly divided into two groups, the control group was treated with mecobalamine, the experimental group was treated with alprostadil on the basis of the treatment of the control group. The efficacy of two groups was observed and compared. Results The total effective rate of 51 cases in the experimental group was 94.23%, higher than that of the patients in the control group(P0.05); median nerve motor conduction velocity and sensory conduction velocity were higher than those of the control group(P0.05), the differences were statistically significant. Conclusion Alprostadil has good effect on diabetic peripheral neuropathy, which can improve the therapeutic effect, accelerate nerve conduction velocity, and is worthy of application.

About this research paper

What this paper is about

Objective To study and analyze the effect of alprostadil on diabetic peripheral neuropathy. Methods 102 patients with diabetic peripheral neuropathy were randomly divided into two groups, the control group was treated with mecobalamine, the experimental group was treated with alprostadil on the basis of the treatment of the control group. The efficacy of two groups was observed and compared. Results The total effective rate of 51 cases in the experimental group was 94.23%, higher than that of the patients in the control group(P0.05); median nerve motor conduction velocity and sensory conduction velocity were higher than those of the control group(P0.05), the differences were statistically significant. Conclusion Alprostadil has good effect on diabetic peripheral neuropathy, which can improve the therapeutic effect, accelerate nerve conduction velocity, and is worthy of application.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study and analyze the effect of alprostadil on diabetic peripheral neuropathy. Methods 102 patients with diabetic peripheral neuropathy were randomly divided into two groups, the control group was treated with mecobalamine, the experimental group was treated with alprostadil on the basis of the treatment of the control group. The efficacy of two groups was observed and compared. Results The total effective rate of 51 cases in the experimental group was 94.23%, higher than that of the patients in the control group(P0.05); median nerve motor conduction velocity and sensory conduction velocity were higher than those of the control group(P0.05), the differences were statistically significant. Conclusion Alprostadil has good effect on diabetic peripheral neuropathy, which can improve the therapeutic effect, accelerate nerve conduction velocity, and is worthy of application.

Key concepts: Medicine, Peripheral neuropathy, Nerve conduction velocity, Peripheral, Therapeutic effect, Diabetic neuropathy, Anesthesia, Diabetes mellitus

Related papers

Back to paper searchBrowse research topicsOriginal source
Observation on the Efficacy of Alprostadil in the Treatment of Diabetic Peripheral Neuropathy — Research Paper | ScholarLens